Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

Tony Benna's Sundance-premiered 'André is an Idiot' irreverently chronicles the last years in the life of advertising ...

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

Popular weight loss injections including Ozempic, Wegovy and Mounjaro could increase the risk of thyroid cancer within the ...

Merck's blockbuster drug Keytruda and Eisai's cancer drug Lenvima, in combination with chemotherapy, failed to improve ...

Doctors say new research has found a link between weight-loss drugs and cancer, putting users at 'significantly higher risk' ...

Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Dr. Syed Hussain from Trinity Health of New England has the latest health news on bird flu, and studies on cancer rates in ...

A study has revealed that a delicious hot drink could be the secret to shedding pounds and reducing health risks, all for as ...

For women with newly diagnosed invasive breast cancer (BC), weight gain is associated with an increased risk for heart ...